• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Tretinoin
piperazine citrate; 41372-10-5
Aluminum octanoate
Nitrotetrazolium blue chloride
Glyoxylic acid
Di-(2-ethylhexyl)phoxphate

TUL Degu and Liraglutide insulin compound preparation obtained clinical approval.

April 27, 2023

Tag:

TUL Degu and Liraglutide insulin compound preparation obtained clinical approval.

Previous:350 million project construction started, and the development potential of TUL was accelerated

Next:First in China! The weight management medicine of Smeglutide Injection of TUL was approved for clini

You may like
More>>

1-Iodopentane

1-Iodopentane
Candesartan cilexetil

Candesartan cilexetil
D(-)-Glutamine

D(-)-Glutamine
2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine

2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine
Benzylpenicillin Sodium for injection, 1mega/10ml

Benzylpenicillin Sodium for injection, 1mega/10ml
1-Chlorooctadecane

1-Chlorooctadecane
SUCROSE PALMITATE

SUCROSE PALMITATE
Isopentene

Isopentene
Aztreonam Impurity 28

Aztreonam Impurity 28
3.4-Difluorobenzonitrile

3.4-Difluorobenzonitrile

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service